-
25 July 2024
Ipsen S.A.publie son Rapport financier semestriel 2024 (semestre clos le 30 juin 2024)
Ipsen S.A.publie son Rapport financier semestriel 2024 (semestre clos le 30 juin 2024)...
-
15 February 2024
-
01 April 2026
Ipsen announces the availability of its 2025 Universal Registration Document
Ipsen announces the availability of its 2025 Universal Registration Document...
-
13 May 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026
Annual General Meeting of Ipsen S.A. held on 13 May 2026...
-
30 July 2026
Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance
PARIS, FRANCE, 30 July 2026 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its financial results for the first half of 2026....
-
03 April 2026
Ipsen announces that Beech Tree has obtained an exemption from the obligation to submit a public tender offer
PARIS, FRANCE, 3 April 2026 — Ipsen (Euronext: IPN; ADR: IPSEY) announces that Beech Tree — which directly and indirectly holds 26.03% of Ipsen S.A.’s share capital and 33.05% of its voting rights — has obtained from the French Financial Markets A...
-
29 July 2026
Ipsen nomme Catherine Bradley en tant que nouvelle administratrice indépendante au sein de son Conseil d’administration
Ipsen nomme Catherine Bradley, administratrice indépendante au sein de son Conseil d’administration...
-
20 April 2026
Registered Shareholder – Personal Data Protection Notice
For the purposes of this Global Privacy Notice, Ipsen S.A, headquartered at 70 rue Balard, 75015, Paris, France, and its affiliates, are data controllers for the personal data processing described (referred to as Ipsen, we or us in this notice)....
-
26 May 2027
-
26 May 2027